UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048507
Receipt number R000055279
Scientific Title The effects of dietary and exercise interventions on physical function in older adults
Date of disclosure of the study information 2022/08/09
Last modified on 2023/10/31 14:39:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of diet and physical activity on physical function in older adults

Acronym

The effects of diet and physical activity on physical function

Scientific Title

The effects of dietary and exercise interventions on physical function in older adults

Scientific Title:Acronym

The effects of dietary and exercise interventions on physical function

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effects of milk constituent supplementation and physical activity on physical function in older women.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Physical function tests

Key secondary outcomes

Questionnaires on quality of life and daily life


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Prevention

Type of intervention

Food Behavior,custom

Interventions/Control_1

Participants consume a milk constituent supplement per day for 12 weeks. The outcomes are measured at baseline, 4 weeks, 8 weeks and 12 weeks.

Interventions/Control_2

Participants consume a placebo supplement per day for 12 weeks. The outcomes are measured at baseline, 4 weeks, 8 weeks and 12 weeks.

Interventions/Control_3

Participants consume a milk constituent supplement per day and increase their daily activity for 12 weeks. The outcomes are measured at baseline, 4 weeks, 8 weeks and 12 weeks.

Interventions/Control_4

Participants consume a placebo supplement per day and increase their daily activity for 12 weeks. The outcomes are measured at baseline, 4 weeks, 8 weeks and 12 weeks.

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit

79 years-old >=

Gender

Female

Key inclusion criteria

1.Participants who are aged 60-79 years old.
2.Participants who are able to spend activity their daily life although they have lower physical function.
3.Participants who have no medical and surgical disorders.
4.Participants who are non-smokers.
5.Participants who have not gained or reduced weight in the past 3 months or who will not intend to lose weight within the examination period.
6.Participants who have no milk allergies
7.Participants who have no protein restriction.
8.Participants who are not dementia.
9.Participants who have no requirement for a certification of needed long-term care.
10.Participants who have no back and knee pains.

Key exclusion criteria

1. Participants who are aged below 59 years old or above 80 years old.
2. Participants who have no issue on physical function or who are not extremely lower daily activity levels.
3. Participants who have medical and surgical disorders.
4. Participants who are smokers.
5. Participants who have gained or reduced weight in the past 3 months or who will intend to lose weight within the examination period.
6. Participants who have milk allergies.
7. Participants who have protein restriction.
8. Participants who are dementia.
9. Participants who have a requirement for a certification of needed long-term care.
10. Participants who have back and knee pains.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Masashi
Middle name
Last name Miyashita

Organization

Waseda University

Division name

Faculty of Sport Sciences

Zip code

359-1192

Address

2-579-15 Mikajima, Tokorozawa, Saitama

TEL

04-2947-6774

Email

m.miyashita@waseda.jp


Public contact

Name of contact person

1st name Masashi
Middle name
Last name Miyashita

Organization

Waseda University

Division name

Faculty of Sport Sciences

Zip code

359-1192

Address

2-579-15 Mikajima, Tokorozawa, Saitama

TEL

04-2947-6774

Homepage URL


Email

m.miyashita@waseda.jp


Sponsor or person

Institute

Waseda University

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Waseda University

Address

1-104 Totsuka-cho, Shinjuku-ku, Tokyo

Tel

03-5272-1639

Email

rinri@list.waseda.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 08 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 12 Month 06 Day

Date of IRB

2022 Year 02 Month 07 Day

Anticipated trial start date

2022 Year 08 Month 10 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 07 Month 29 Day

Last modified on

2023 Year 10 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055279


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name